Restricted accessLetterFirst published online 1990-10
Lack of Correlation between Plasmatic Levels of Retinol and RBP and Thyroid Hormones in Breast Cancer Patients Treated with the Synthetic Retinoid Fenretinide
MoonR.C., ThompsonH.J., BecciJ.P.N (4 Hydroxyph-enil) retinamide. A new retinoid for prevention of breast cancer in the rat. Cancer Res1979; 39: 1339–46.
2.
WelschC.W., DeHoogJ.V., MoonR.C.Inhibition of mammary tumorgenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N (4 hydrpxyphenil) retinamide. Carcinogenesis1983; 4: 1185–7.
3.
FormelliF., CarsanaR., CostaA.N (4hydroxyphenyl) retinamide (4HPR) lowers plasma retinol levels in rats. Med Sci Res1987; 15: 843–4.
4.
FormelliF., CarsanaR., CostaA.Plasma retinol level reduction by the synthetic retinoid Fenretinide: a one year follow up study of breast cancer patients. Cancer Res1989; 49: 6149–52.
5.
LippmanS.M., KesslerJ.F., MeyskensF.L.Retinoids as preventive annd therapeutic anticancer agents (Part I). Cancer Treat Rep1987; 4: 391–405.
